InvestorsHub Logo
Followers 138
Posts 22885
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Wednesday, 12/14/2022 12:48:03 PM

Wednesday, December 14, 2022 12:48:03 PM

Post# of 458721
A question:

Based on the following do you think that the FDA will approve Eisai and Biogen's Lencanmab in 2023.

Lecanemab and other drugs that remove amyloid have another side effect that is more mysterious: They seem to cause the brain to shrink. That concerns scientists including Thambisetty. "Brain shrinkage represents disease progression," he says.



https://www.npr.org/sections/health-shots/2022/12/08/1141396375/lecanemab-alzheimer-drug-researchers-hope



Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News